| pubmed-article:17643202 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C0150369 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C1704689 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C0025932 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C1705150 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C0007137 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C0046056 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C0751688 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C0812298 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:17643202 | lifeskim:mentions | umls-concept:C0086126 | lld:lifeskim |
| pubmed-article:17643202 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:17643202 | pubmed:dateCreated | 2007-10-23 | lld:pubmed |
| pubmed-article:17643202 | pubmed:abstractText | The uptake of 3'-[18F]fluoro-3'-deoxythymidine (FLT), a proliferation marker, was measured before and during fractionated radiotherapy to evaluate the potential of FLT-positron emission tomography (PET) imaging as an indicator of tumor response compared to 2'-deoxy-2'-[18F]fluoro-D-glucose (FDG). | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17643202 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17643202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17643202 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17643202 | pubmed:issn | 1536-1632 | lld:pubmed |
| pubmed-article:17643202 | pubmed:author | pubmed-author:LammertsmaAdr... | lld:pubmed |
| pubmed-article:17643202 | pubmed:author | pubmed-author:MolthoffCarla... | lld:pubmed |
| pubmed-article:17643202 | pubmed:author | pubmed-author:SlotmanBen... | lld:pubmed |
| pubmed-article:17643202 | pubmed:author | pubmed-author:KlabbersBianc... | lld:pubmed |
| pubmed-article:17643202 | pubmed:author | pubmed-author:BerkhofJohann... | lld:pubmed |
| pubmed-article:17643202 | pubmed:author | pubmed-author:WindhorstAlbe... | lld:pubmed |
| pubmed-article:17643202 | pubmed:author | pubmed-author:FeltenJasper... | lld:pubmed |
| pubmed-article:17643202 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:17643202 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17643202 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:17643202 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17643202 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17643202 | pubmed:pagination | 340-7 | lld:pubmed |
| pubmed-article:17643202 | pubmed:dateRevised | 2010-9-15 | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:meshHeading | pubmed-meshheading:17643202... | lld:pubmed |
| pubmed-article:17643202 | pubmed:articleTitle | Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2'-deoxy-2'-[18F]fluoro-D-glucose (FDG) and 3'-[18F]fluoro-3'-deoxythymidine (FLT). | lld:pubmed |
| pubmed-article:17643202 | pubmed:affiliation | Department of Nuclear Medicine and PET Research, VU University Medical Center, P.O. Box 7057, 1007, Amsterdam, The Netherlands. cfm.molthoff@vumc.nl | lld:pubmed |
| pubmed-article:17643202 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17643202 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17643202 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17643202 | lld:pubmed |
